Advertisement
U.S. markets closed
Advertisement

Armata Pharmaceuticals, Inc. (ARMP)

NYSE American - Nasdaq Real Time Price. Currency in USD
Visitors trend2W10W9M
2.7000-0.0900 (-3.23%)
At close: 02:28PM EST
2.7000 0.00 (0.00%)
After hours: 06:44PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Fast Stochastic

Fast Stochastic

Performance Outlook
Previous Close2.7900
Open2.7000
Bid1.9700 x 1100
Ask2.7600 x 3000
Day's Range2.5827 - 2.7000
52 Week Range0.8300 - 5.2600
Volume9,351
Avg. Volume17,420
Market Cap97.596M
Beta (5Y Monthly)0.61
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for ARMP

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Armata Pharmaceuticals, Inc.
    Analyst Report: Pfizer Inc.Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
    Rating
    Fair Value
    Economic Moat
    10 days agoMorningstar
View more